EUCTR2004-001277-25-IT进行中（未招募）不适用
A Phase III, Multicentre, Double Blinded Study in Patients with Chronic Hepatitis C who are Non-responders to prior PEGinterferon alpha + Ribavirin Therapy Comparing Treatment with Thymosin alpha 1 + PEGinterferon alfa-2a plus Ribavirin with PEGinterferon alfa-2a + Ribavirin + Placebo
SIGMA-TA0 个研究点目标入组 550 人开始时间: 2005年4月13日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 550
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A Phase III, Multicentre, Double Blinded Study In Patients With Chronic Hepatitis C Who Are Non-Responders To Prior Peginterferon Alpha + Ribavirin Therapy Comparing Treatment With Thymosin Alpha 1 + Peginterferon Alfa-2a + Ribavirin With Peginterferon Alfa-2a + Ribavirin + Placebo.treatment of patients with Chronic Hepatitis C who are Non-responders to a course with approved doses of PEGinterferon alpha + RibavirinEUCTR2004-001277-25-ESSigma-Tau Industrie Farmaceutiche Riunite S.p.A.550
进行中（未招募）
不适用
A Phase III, Multicentre, Double Blinded Study In Patients With Chronic Hepatitis C Who Are Non-Responders To Prior Peginterferon Alpha + Ribavirin Therapy Comparing Treatment With Thymosin Alpha 1 + Peginterferon Alfa-2a + Ribavirin With Peginterferon Alfa-2a + Ribavirin + Placebo. - N/AEUCTR2004-001277-25-DESigma-Tau Industrie Farmaceutiche Riunite S.p.A.550
进行中（未招募）
1 期
Comparative Efficacy and Safety Study of RGB-14-P and Prolia in Women with Postmenopausal OsteoporosisMedDRA version: 20.0Level: PTClassification code 10031285Term: Osteoporosis postmenopausalSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersPostmenopausal osteoporosisEUCTR2020-006017-38-CZGedeon Richter Plc.434
进行中（未招募）
1 期
Comparative Efficacy and Safety Study of RGB-14-P and Prolia in Women with Postmenopausal OsteoporosisPostmenopausal osteoporosisEUCTR2020-006017-38-PLGedeon Richter Plc.434
进行中（未招募）
1 期
Comparative Efficacy and Safety Study of RGB-14-P and Prolia in Women with Postmenopausal OsteoporosisPostmenopausal osteoporosisEUCTR2020-006017-38-BGGedeon Richter Plc.434